GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Healthcare Investors (NYSE:HQH) » Definitions » 5-Year RORE %

abrdn Healthcare Investors (abrdn Healthcare Investors) 5-Year RORE % : -67.14% (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is abrdn Healthcare Investors 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. abrdn Healthcare Investors's 5-Year RORE % for the quarter that ended in Sep. 2023 was -67.14%.

The industry rank for abrdn Healthcare Investors's 5-Year RORE % or its related term are showing as below:

HQH's 5-Year RORE % is ranked worse than
85.88% of 1374 companies
in the Asset Management industry
Industry Median: 6.925 vs HQH: -67.14

abrdn Healthcare Investors 5-Year RORE % Historical Data

The historical data trend for abrdn Healthcare Investors's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Healthcare Investors 5-Year RORE % Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
5-Year RORE %
Get a 7-Day Free Trial - - - - -67.14

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 35.90 -67.14

Competitive Comparison of abrdn Healthcare Investors's 5-Year RORE %

For the Asset Management subindustry, abrdn Healthcare Investors's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors's 5-Year RORE % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's 5-Year RORE % falls into.



abrdn Healthcare Investors 5-Year RORE % Calculation

abrdn Healthcare Investors's 5-Year RORE % for the quarter that ended in Sep. 2023 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 1.09--3.53 )/( 2.169-9.05 )
=4.62/-6.881
=-67.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2023 and 5-year before.


abrdn Healthcare Investors  (NYSE:HQH) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


abrdn Healthcare Investors 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of abrdn Healthcare Investors's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


abrdn Healthcare Investors (abrdn Healthcare Investors) Business Description

Traded in Other Exchanges
N/A
Address
900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
Executives
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022

abrdn Healthcare Investors (abrdn Healthcare Investors) Headlines

From GuruFocus

Tekla Healthcare Investors Paid Distribution

By Business Wire Business Wire 06-30-2022

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 11-12-2021

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 08-17-2021

Tekla Healthcare Investors Paid Distribution

By Business Wire Business Wire 06-30-2021

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 08-16-2022

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 02-15-2022